Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 20;25(1):188.
doi: 10.1186/s12876-025-03785-3.

Diagnostic performance of contrast-enhanced CT combined with contrast-enhanced MRI for colorectal liver metastases: a case-control study

Affiliations

Diagnostic performance of contrast-enhanced CT combined with contrast-enhanced MRI for colorectal liver metastases: a case-control study

Luxian Zhang et al. BMC Gastroenterol. .

Abstract

Background: Colorectal liver metastases (CRLM) are a major determinant of prognosis in colorectal cancer (CRC) patients. Their early and accurate detection is essential for appropriate therapeutic planning and improving survival outcomes.

Purpose: To evaluate the diagnostic capabilities of contrast-enhanced computed tomography (CT) and contrast-enhanced magnetic resonance imaging (MRI) in detecting colorectal liver metastases.

Materials and methods: We employed a case-control design to compare patients with histologically confirmed liver metastases against a control group without the condition. A total of 85 patients in each group were selected and retrospectively matched based on relevant factors. All subjects underwent both contrast-enhanced CT and MRI. The diagnostic performance of these imaging modalities was assessed by analysing sensitivity, specificity, positive and negative predictive values, and radiologists' diagnostic confidence. Kappa statistics were used to evaluate inter-observer agreement. All MRI scans were performed using a 3-Tesla (3-T) MRI scanner to ensure high-quality imaging and detailed lesion characterization. And all the scans were reviewed by two radiologists.

Results: The combination of contrast-enhanced CT and MRI demonstrated a statistically significant improvement in sensitivity (90.6% for MRI alone vs. 96.5% for combined modalities) and specificity (95.3% for MRI alone vs. 98.3% for combined modalities). Positive and negative predictive values were similarly enhanced. Radiologists' diagnostic confidence was higher with combined imaging, achieving a 'very high' confidence level in 78.8% of cases compared with 64.7% for MRI alone. The inter-observer agreement reached 'almost perfect' status with the combined approach.

Conclusion: The integration of contrast-enhanced CT with MRI significantly enhanced the diagnostic accuracy for colorectal liver metastases, representing a valuable tool for the preoperative evaluation of patients with CRC.

Clinical trial number: Not applicable.

Keywords: Colorectal cancer; Computed tomography; Contrast-enhanced MRI; Diagnostic imaging; Liver metastases; Magnetic resonance imaging.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The Ethics Committee of Zhongshan Hospital Xiamen University, Xiamen City, Fujian Province, China approved the study. All participants were provided with a written informed consent form, clearly stating that their participation in the study was voluntary and that they had the right to withdraw at any time without facing any consequences. The participants guardians were provided with detailed explanations about the confidentiality of their information. Written informed consent was obtained from all participants. All methods were carried out in accordance with relevant guidelines and regulations. Consent for publication: None. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Enhanced T1-weighted MRI (sagittal view) showing sigmoid-rectal wall thickening and lumen stenosis in a 50-year-old female
Fig. 2
Fig. 2
CT image during the delayed phase showing a low-density lesion in the upper segment of the right anterior lobe (S8) of the liver (axial view)
Fig. 3
Fig. 3
CT image during the portal phase showing two low-density lesions in the upper right anterior liver lobe (S8) (coronary view)
Fig. 4
Fig. 4
T1-weighted MRI during the portal phase depicting a lesion with low signal intensity and uneven internal signal in the upper segment of the right anterior lobe (S8) (axial view)
Fig. 5
Fig. 5
MRI image during the portal phase showing two lesions with slightly lower signal intensities in the right anterior upper lobe of the liver (S8), featuring uneven internal signals (coronary view)

Similar articles

Cited by

References

    1. Ghani M, Fereydooni A, Chen E. Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy. Eur Radiol. 2021;31:8858–67. - PMC - PubMed
    1. Attiyeh M, Malhotra G, Li D. Defining MRI superiority over CT for colorectal and neuroendocrine liver metastases. Cancers (Basel). 2023;23:5109. - PMC - PubMed
    1. Wang Y, Ma L, Yin X. Radiomics and radiogenomics in evaluation of colorectal cancer liver metastasis. Front Oncol. 2022;11:689509. - PMC - PubMed
    1. Niekel M, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010;257(674– 84). - PubMed
    1. Floriani I, Torri V, Rulli E. Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging. 2010;31:19–31. - PubMed